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Purpose: Menthol containing topical analgesic gels are used clinically to activate 
transient receptor potential melastatin 8 (TRPM8) receptors, which elicits a cold 
sensation that purportedly mimics cryotherapy. However, there is controversy as to the 
precise vascular effects of menthol containing topical analgesics. We sought to more 
fully characterize the mechanism(s) of action through which topical menthol application 
may alter skin blood flow (SkBF). Methods: Three distinct protocols were conducted in 
three groups of 10 young, healthy subjects. Red cell flux was measured via laser speckle 
contrast imaging in all protocols. Protocol 1: Menthol (4%) and placebo gels were 
applied to 45cm2 of skin without thermal control and SkBF was measured until SkBF 
reached a stable plateau. Protocol 2: Menthol and placebo gels were applied to skin under 
local thermal control (33⁰C). Post-occlusive reactive hyperemia (PORH) and local 
heating (42⁰C) protocols were conducted to determine the contribution of endothelium 
derived hyperpolarizing factors (EDHFs) and nitric oxide, respectively. Protocol 2 was 
repeated with Lidocaine pretreatment to determine sensory nerve contribution. Protocol 
3: Seven concentrations of menthol gel (0.04%, 0.4%, 1%, 2%, 4%, 7%, 8%) were 
applied to the skin to model the dose-response relation between menthol and SkBF. Data 
for all protocols were normalized to cutaneous vascular conductance (CVC: flux/mean 
pressure) and expressed as percent maximum CVC (%CVCmax) where appropriate. 
Results: Protocol 1: menthol gel increased SkBF compared to placebo (3.4±0.3 v 1.1±0.2 
CVC: p<0.001). Protocol 2: menthol augmented SkBF compared to placebo during 
baseline (63±7 v 20±2 %CVCmax; p<0.001), PORH (90±4 v 69±5 %CVCmax; p<0.001), 
and local heating (81±2 v 74±3 %CVCmax; p=0.03). Sensory nerve inhibition attenuated 
menthol-mediated dilation at baseline (32±4 %CVCmax; p<0.001) and PORH (70±5 
%CVCmax; p<0.001). Protocol 3: SkBF increased with increasing doses of menthol (main 
effect, p<0.05). Pharmacological curve modeling indicated that the ED50 for menthol was 
a 1% concentration. Conclusion: Topically applied menthol dose-dependently increases 
blood flow in the cutaneous microvasculature. This increase in blood flow is mediated in 
part by EDHFs and sensory nerves.  	  
